⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CNTB News
Connect Biopharma Holdings Limited Ordinary Shares
Form 8-K
sec.gov
CNTB
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
globenewswire.com
CNTB
Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth
businesswire.com
CNTB
Form 8-K
sec.gov
CNTB
Connect Biopharma Announces $20.2 Million Private Placement Financing
globenewswire.com
CNTB
Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
globenewswire.com
CNTB
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
globenewswire.com
CNTB
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
CNTB
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
CNTB
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
globenewswire.com
CNTB